MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $32,506,124 | -3.5% | 116,027 | -20.3% | 0.01% | -16.7% |
| Q4 2023 | $33,686,383 | +7.7% | 145,589 | +7.5% | 0.01% | 0.0% |
| Q2 2023 | $31,279,017 | +10.7% | 135,407 | +16.1% | 0.01% | 0.0% |
| Q1 2023 | $28,245,336 | -16.3% | 116,591 | +0.3% | 0.01% | -25.0% |
| Q4 2022 | $33,756,075 | +346.6% | 116,300 | 0.0% | 0.01% | +300.0% |
| Q3 2022 | $7,558,337 | -3.6% | 116,300 | +6.2% | 0.00% | 0.0% |
| Q2 2022 | $7,838,439 | -27.0% | 109,506 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $10,744,729 | +15.8% | 109,506 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $9,280,000 | +15.2% | 109,506 | +8.4% | 0.00% | 0.0% |
| Q3 2021 | $8,059,000 | +12.3% | 101,006 | +37.1% | 0.00% | 0.0% |
| Q2 2021 | $7,175,000 | -42.4% | 73,659 | -30.9% | 0.00% | -33.3% |
| Q1 2021 | $12,465,000 | -25.0% | 106,566 | -28.7% | 0.00% | -25.0% |
| Q4 2020 | $16,619,000 | -12.2% | 149,488 | -6.3% | 0.00% | -20.0% |
| Q3 2020 | $18,935,000 | +17.9% | 159,482 | +12.5% | 0.01% | 0.0% |
| Q2 2020 | $16,057,000 | +81.3% | 141,788 | +6.9% | 0.01% | +66.7% |
| Q1 2020 | $8,856,000 | -24.4% | 132,652 | +3.2% | 0.00% | 0.0% |
| Q4 2019 | $11,712,000 | +56.3% | 128,545 | +47.9% | 0.00% | +50.0% |
| Q3 2019 | $7,493,000 | -13.2% | 86,899 | +5.5% | 0.00% | -33.3% |
| Q2 2019 | $8,632,000 | -16.3% | 82,350 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $10,315,000 | +11.1% | 82,350 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $9,282,000 | -28.9% | 82,350 | +35.1% | 0.00% | -25.0% |
| Q3 2018 | $13,052,000 | – | 60,954 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |